Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica

Por Bennett, Jeffrey L.
Publicado no J Neuroophthalmol (2016)

Optic Neuritis

Por Bennett, Jeffrey L.
Publicado no Continuum (Minneap Minn) (2019)

Acute Management of Optic Neuritis: An Evolving Paradigm

Por Horton, Lindsay, Bennett, Jeffrey L.
Publicado no J Neuroophthalmol (2018)

Pharmacological Properties, Toxicology and Scientific Rationale for the use of Natalizumab (Tysabri®) in Inflammatory Diseases

Por Stüve, Olaf, Bennett, Jeffrey L.
Publicado no CNS Drug Rev (2007)

Recent advances in the treatment of multiple sclerosis

Por Bennett, Jeffrey L, Miravalle, Augusto A
Publicado no J Exp Pharmacol (2010)

Trigger, pathogen, or bystander: the complex nexus linking Epstein–Barr virus and multiple sclerosis

Por Owens, Gregory P, Bennett, Jeffrey L
Publicado no Mult Scler (2012)

Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy

Por Bennett, Jeffrey L., Owens, Gregory P.
Publicado no J Neuroophthalmol (2017)

Intravenous Neuromyelitis Optica Autoantibody in Mice Targets Aquaporin-4 in Peripheral Organs and Area Postrema

Por Ratelade, Julien, Bennett, Jeffrey L., Verkman, A. S.
Publicado em 2011

Evidence against Cellular Internalization in Vivo of NMO-IgG, Aquaporin-4, and Excitatory Amino Acid Transporter 2 in Neuromyelitis Optica

Por Ratelade, Julien, Bennett, Jeffrey L., Verkman, A. S.
Publicado em 2011

EX VIVO SPINAL CORD SLICE MODEL OF NEUROMYELITIS OPTICA REVEALS NOVEL IMMUNOPATHOGENIC MECHANISMS

Por Zhang, Hua, Bennett, Jeffrey L., Verkman, A. S.
Publicado em 2011

Live Cell Analysis of Aquaporin-4 M1/M23 Interactions and Regulated Orthogonal Array Assembly in Glial Cells

Por Crane, Jonathan M., Bennett, Jeffrey L., Verkman, A. S.
Publicado em 2009

OPTIC NEURITIS IN NEUROMYELITIS OPTICA

Por Levin, Marc H., Bennett, Jeffrey L., Verkman, A.S.
Publicado em 2013

The Treatment of Neuromyelitis Optica

Por Kowarik, Markus C., Soltys, John, Bennett, Jeffrey L.
Publicado em 2014

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies

Por Papadopoulos, Marios C., Bennett, Jeffrey L., Verkman, Alan S.
Publicado no Nat Rev Neurol (2014)

The Ins and Outs of B Cells in Multiple Sclerosis

Por Blauth, Kevin, Owens, Gregory P., Bennett, Jeffrey L.
Publicado no Front Immunol (2015)

Considerations for the Treatment of Inflammatory Neuro-Ophthalmologic Disorders During the COVID-19 Pandemic

Por Martin Paez, Yosbelkys, Bennett, Jeffrey L., Subramanian, Prem S., Pelak, Victoria S.
Publicado no J Neuroophthalmol (2020)

Postmortem changes in the neuroanatomical characteristics of the primate brain: the hippocampal formation

Por Lavenex, Pierre, Lavenex, Pamela Banta, Bennett, Jeffrey L., Amaral, David G.
Publicado em 2009

Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica

Por Rossi, Andrea, Ratelade, Julien, Papadopoulos, Marios C., Bennett, Jeffrey L., Verkman, A. S.
Publicado em 2012

Neuromyelitis Optica IgG Does Not Alter Aquaporin-4 Water Permeability, Plasma Membrane M1/M23 Isoform Content, or Supramolecular Assembly

Por Rossi, Andrea, Ratelade, Julien, Papadopoulos, Marios C., Bennett, Jeffrey L., Verkman, A. S.
Publicado em 2012

Orthogonal array formation by human aquaporin-4: Examination of neuromyelitis optica-associated aquaporin-4 polymorphisms

Por Crane, Jonathan M., Rossi, Andrea, Gupta, Tripta, Bennett, Jeffrey L., Verkman, A.S.
Publicado em 2011